The expanding universe of disorders of the basal ganglia

The Lancet

Volumn 384, Issue 9942, 2014, Pages 523-531

  Obeso, Jose A ^a,b   Rodriguez Oroz, Maria C ^b,c   Stamelou, Maria ^d,e   Bhatia, Kailash P ^e   Burn, David J ^f  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LEVODOPA; PARKIN; RACLOPRIDE;

AKINESIA; BASAL GANGLION; BEHAVIOR DISORDER; CLINICAL FEATURE; COGNITION; DYSKINESIA; EMOTION; GENETIC VARIABILITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERKINESIA; IMPULSIVENESS; MENTAL DISEASE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; ARTICLE; EXTRAPYRAMIDAL SYNDROME; GENETICS; PHENOTYPE;

BASAL GANGLIA; BASAL GANGLIA DISEASES; HUMANS; LIMBIC SYSTEM; MOVEMENT DISORDERS; PARKINSON DISEASE; TOURETTE SYNDROME;

EID: 84906323786     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62418-6     Document Type: Review

References (83)

1. S Wilson Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver Brain 34 1912 295 509
2. J Purdon Martin Hemichorea resulting from a location lesion of the brain (the syndrome of the body of Luys) Brain 50 1927 637 651
3. M Parent, A Parent Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship Can J Neurol Sci 37 2010 313 319
4. S Wilson Disorders of motility and tone Lancet 1 1925 1 103
5. H Ehringer, O Hornykiewicz [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system] Klin Wochenschr 38 1960 1236 1239
6. CD Marsden The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture Neurology 32 1982 514 539
7. AR Crossman Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders Neuroscience 21 1987 1 40
8. IJ Mitchell, CE Clarke, S Boyce et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neuroscience 32 1989 213 226
9. RL Albin, AB Young, JB Penney The functional anatomy of basal ganglia disorders Trends Neurosci 12 1989 366 375
10. MR DeLong Primate models of movement disorders of basal ganglia origin Trends Neurosci 13 1990 281 285
11. GE Alexander, MR DeLong, PL Strick Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu Rev Neurosci 9 1986 357 381
12. S Lehéricy, E Bardinet, L Tremblay et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches Cereb Cortex 16 2006 149 161
13. C Lambert, L Zrinzo, Z Nagy et al. Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging Neuroimage 60 2012 83 94
14. JA Obeso, MC Rodriguez-Oroz, M Rodriguez, MR DeLong, CW Olanow Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model Ann Neurol 47 suppl 1 2000 S22 S32 discussion S32-34.
15. CD Marsden, JA Obeso The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease Brain 117 1994 877 897
16. L Wilkinson, M Jahanshahi The striatum and probabilistic implicit sequence learning Brain Res 1137 2007 117 130
17. O Hikosaka, M Isoda Switching from automatic to controlled behavior: cortico-basal ganglia mechanisms Trends Cogn Sci 14 2010 154 161
18. J Doyon, P Bellec, R Amsel et al. Contributions of the basal ganglia and functionally related brain structures to motor learning Behav Brain Res 199 2009 61 75
19. AR Aron, RA Poldrack Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus J Neurosci 26 2006 2424 2433
20. M Alegre, J Lopez-Azcarate, I Obeso et al. The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease Exp Neurol 239 2013 1 12
21. C Baunez, TW Robbins Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial reaction time task in rats Psychopharmacology (Berl) 141 1999 57 65
22. Obeso I, Wilkinson E, Casanova E, et al. Involvement of the subthalamic nucleus in inhibitory control and adjusting response thresholds. Evidence from unilateral subthalamotomy in Parkinson's disease. Brain (in press).
23. D Weintraub, J Koester, MN Potenza et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Arch Neurol 67 2010 589 595
24. J Bastiaens, BJ Dorfman, PJ Christos, MJ Nirenberg Prospective cohort study of impulse control disorders in Parkinson's disease Mov Disord 28 2013 327 333
25. D Weintraub, K Papay, A Siderowf the Parkinson's Progression Markers Initiative Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study Neurology 80 2013 176 180
26. V Voon, PO Fernagut, J Wickens et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders Lancet Neurol 8 2009 1140 1149
27. R Cilia, JH Ko, SS Cho et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling Neurobiol Dis 39 2010 98 104
28. TD Steeves, J Miyasaki, M Zurowski et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study Brain 132 2009 1376 1385
29. T van Eimeren, G Pellecchia, R Cilia et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD Neurology 75 2010 1711 1716
30. L Mallet, M Schüpbach, K N'Diaye et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior Proc Natl Acad Sci USA 104 2007 10661 10666
31. MC Rodriguez-Oroz, J López-Azcárate, D Garcia-Garcia et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease Brain 134 2011 36 49
32. M Okun, D Weintraub Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? Mov Disord 28 2013 1915 1919
33. E Lhommée, H Klinger, S Thobois et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours Brain 135 2012 1463 1477
34. AE Cavanna, S Servo, F Monaco, MM Robertson The behavioral spectrum of Gilles de la Tourette syndrome J Neuropsychiatry Clin Neurosci 21 2009 13 23
35. C Ganos, V Roessner, A Münchau The functional anatomy of Gilles de la Tourette syndrome Neurosci Biobehav Rev 37 2013 1050 1062
36. M Hariz, P Blomstedt, L Zrinzo Future of brain stimulation: New targets, new indications, new technology Mov Disord 28 2013 1784 1792
37. HK Park, HJ Kim, SJ Kim, JS Kim, HW Shin, JS Kim From Jekyll to Hyde after limbic subthalamic nucleus infarction Neurology 77 2011 82 84
38. T Foltynie, CE Brayne, TW Robbins, RA Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain 127 2004 550 560
39. D Muslimovic, B Post, JD Speelman, B Schmand Cognitive profile of patients with newly diagnosed Parkinson disease Neurology 65 2005 1239 1245
40. JS Reijnders, U Ehrt, WE Weber, D Aarsland, AF Leentjens A systematic review of prevalence studies of depression in Parkinson's disease Mov Disord 23 2008 183 189 quiz 313.
41. DA Gallagher, A Schrag Psychosis, apathy, depression and anxiety in Parkinson's disease Neurobiol Dis 46 2012 581 589
42. DJ Burn, S Landau, JV Hindle the PROMS-PD Study Group Parkinson's disease motor subtypes and mood Mov Disord 27 2012 379 386
43. PG Frisina, V Haroutunian, LS Libow The neuropathological basis for depression in Parkinson's disease Parkinsonism Relat Disord 15 2009 144 148
44. NI Bohnen, DI Kaufer, R Hendrickson, GM Constantine, CA Mathis, RY Moore Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia J Neurol Neurosurg Psychiatry 78 2007 641 643
45. GW Duncan, MJ Firbank, JT O'Brien, DJ Burn Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? Mov Disord 28 2013 425 438
46. L Donker Kaat, AJ Boon, W Kamphorst, R Ravid, HJ Duivenvoorden, JC van Swieten Frontal presentation in progressive supranuclear palsy Neurology 69 2007 723 729
47. BC Ghosh, AJ Calder, PV Peers et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy Brain 135 2012 2089 2102
48. KV Papp, RF Kaplan, PJ Snyder Biological markers of cognition in prodromal Huntington's disease: a review Brain Cogn 77 2011 280 291
49. MJ Novak, JD Warren, SM Henley, B Draganski, RS Frackowiak, SJ Tabrizi Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease Brain 135 2012 1165 1179
50. E van Duijn, EM Kingma, RC van der Mast Psychopathology in verified Huntington's disease gene carriers J Neuropsychiatry Clin Neurosci 19 2007 441 448
51. M Svetel, A Potrebić, T Pekmezović et al. Neuropsychiatric aspects of treated Wilson's disease Parkinsonism Relat Disord 15 2009 772 775
52. KJ Peall, AJ Waite, DJ Blake, MJ Owen, HR Morris Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review Mov Disord 26 2011 1939 1942
53. MJ van Tricht, YE Dreissen, D Cath et al. Cognition and psychopathology in myoclonus-dystonia J Neurol Neurosurg Psychiatry 83 2012 814 820
54. M Stamelou, MJ Edwards, M Hallett, KP Bhatia The non-motor syndrome of primary dystonia: clinical and pathophysiological implications Brain 135 2012 1668 1681
55. K Lohmann, C Klein Genetics of dystonia: what's known? What's new? What's next? Mov Disord 28 2013 899 905
56. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
57. MH Polymeropoulos, C Lavedan, E Leroy et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
58. M Stamelou, NE Mencacci, C Cordivari et al. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency Neurology 79 2012 435 441
59. A Djarmati, SA Schneider, K Lohmann et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study Lancet Neurol 8 2009 447 452
60. H Houlden, SA Schneider, R Paudel et al. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia Neurology 74 2010 846 850
61. S Ohshima, Y Tsuboi, A Yamamoto et al. Autonomic failures in Perry syndrome with DCTN1 mutation Parkinsonism Relat Disord 16 2010 612 614
62. E Apartis, A Blancher, WG Meissner et al. FXTAS: new insights and the need for revised diagnostic criteria Neurology 79 2012 1898 1907
63. NL Khan, E Graham, P Critchley et al. Parkin disease: a phenotypic study of a large case series Brain 126 2003 1279 1292
64. G Kägi, C Klein, NW Wood et al. Nonmotor symptoms in Parkin gene-related parkinsonism Mov Disord 25 2010 1279 1284
65. M Hutchinson, O Kimmich, A Molloy et al. The endophenotype and the phenotype: Temporal discrimination and adult-onset dystonia Mov Disord 28 2013 1766 1774
66. EL Heinzen, KJ Swoboda, Y Hitomi the European Alternating Hemiplegia of Childhood (AHC) Genetics Consortium the Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortium the European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortium De novo mutations in ATP1A3 cause alternating hemiplegia of childhood Nat Genet 44 2012 1030 1034
67. H Rosewich, H Thiele, A Ohlenbusch et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study Lancet Neurol 11 2012 764 773
68. AS Chen-Plotkin, M Martinez-Lage, PM Sleiman et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration Arch Neurol 68 2011 488 497
69. I Le Ber, A Camuzat, D Hannequin the French research network on FTD/FTD-MND Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study Brain 131 2008 732 746
70. J Cooper-Knock, C Hewitt, JR Highley et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72 Brain 135 2012 751 764
71. S Lesage, I Le Ber, C Condroyer the French Parkinson's Disease Genetics Study Group C9orf72 repeat expansions are a rare genetic cause of parkinsonism Brain 136 2013 385 391
72. S O'Dowd, D Curtin, AJ Waite et al. C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism Mov Disord 27 2012 1072 1074
73. M Stamelou, N Quinn, K Bhatia "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide Mov Disord 28 2013 1184 1199
74. WJ Chen, Y Lin, ZQ Xiong et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia Nat Genet 43 2011 1252 1255
75. HY Lee, Y Huang, N Bruneau et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions Cell Rep 1 2012 2 12
76. AR Gardiner, KP Bhatia, M Stamelou et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine Neurology 79 2012 2115 2121
77. RC Dale, A Gardiner, J Antony, H Houlden Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine Dev Med Child Neurol 54 2012 958 960
78. SA Schneider, KE Marshall, J Xiao, MS LeDoux JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family Neurogenetics 13 2012 133 140
79. G Stevanin, H Fujigasaki, AS Lebre et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes Brain 126 2003 1599 1603
80. I Martin, VL Dawson, TM Dawson Recent advances in the genetics of Parkinson's disease Annu Rev Genomics Hum Genet 12 2011 301 325
81. E Sidransky, G Lopez The link between the GBA gene and parkinsonism Lancet Neurol 11 2012 986 998
82. GK Tofaris Lysosome-dependent pathways as a unifying theme in Parkinson's disease Mov Disord 27 2012 1364 1369
83. AB Singleton, MJ Farrer, V Bonifati The genetics of Parkinson's disease: progress and therapeutic implications Mov Disord 28 2013 14 23